Effects of Intrauterine Growth Restriction (IUGR) on Growth and Body Composition Compared to Constitutionally Small

Elisabeth Calek1, Julia Binder2, Pilar Palmrich2

  • 1Division of Neonatology, Pediatric Intensive Care Medicine and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, 1090 Vienna, Austria.

Nutrients
|October 14, 2023
PubMed

Insights

Intrauterine growth restriction (IUGR) significantly impacts infant fat-free mass (FFM) and growth velocity. Early nutritional intervention is crucial for IUGR infants to prevent impaired development and FFM loss.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nutrition
  • Developmental Biology

Background:

  • Intrauterine growth restriction (IUGR) is linked to significant morbidities, including impaired neurodevelopment and growth restriction.
  • Small for gestational age (SGA) is often used as a proxy for IUGR but can also include constitutionally small infants, necessitating differentiation for appropriate nutritional management.

Purpose of the Study:

  • To compare body composition and growth velocity in infants with IUGR, SGA, and appropriate for gestational age (AGA) at term-equivalent age.
  • To determine the impact of being constitutionally small (SGA) versus growth-restricted (IUGR) on infant body composition.

Main Methods:

  • Retrospective analysis of 300 infants (2017-2022) born preterm (<37 weeks gestation).
  • Body composition (fat-free mass [FFM] and fat mass [FM]) and weight growth velocity were measured at term-equivalent age.
  • Comparison of infants with IUGR (n=40) and SGA (n=11) against AGA controls (n=249).

Main Results:

  • IUGR infants exhibited significantly lower FFM (p < 0.001) and weight growth velocity (p = 0.022) compared to AGA infants.
  • No significant differences in FFM or weight growth velocity were observed between SGA and AGA infants.
  • FFM Z-scores were significantly lower in IUGR infants (p = 0.017) compared to AGA, while SGA infants showed no impact on growth or body composition.

Conclusions:

  • Infants born with IUGR demonstrate distinct differences in FFM and growth compared to constitutionally small SGA infants.
  • Early and aggressive nutritional management is essential for IUGR infants to mitigate impaired growth and preserve FFM.
  • Differentiating IUGR from SGA is critical for tailoring nutritional strategies and improving long-term outcomes.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.5K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
383
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K